Analyst Coverage

FirmAnalyst
Argus Research CompanyDavid Toung
Atlantic EquitiesSteve Chesney
BairdBrian Skorney
Bank of America Merrill LynchYing Huang
BarclaysGeoff  Meacham
BMOIan Somaiya
CitiRobyn Karnauskas
Cowen & CompanyPhil Nadeau, PhD
Credit SuisseAlethia Young
Evercore ISIMark Schoenebaum
Goldman Sachs & Co.Terence Flynn, PhD
Guggenheim SecuritiesTony Butler
JefferiesBrian Abrahams, M.D.
JPMorganCory Kasimov
Leerink PartnersGeoffrey Porges, MBBS
Maxim GroupJason Kolbert
MizuhoSalim Syed
Morgan StanleyMatthew Harrison
MorningstarKaren Andersen, CFA
NeedhamAlan Carr
Piper Jaffray & Co.Joshua Schimmer, MD
RBC Capital MarketsMichael  Yee
Standard and PoorsSteven Silver
StifelKatherine Breedis
UBSMark Goodman
Wells FargoJim Birchenough
William Blair & CompanyJohn Sonnier
Gilead Sciences is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Gilead Sciences's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Gilead Sciences or its management. Gilead Sciences does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
NASDAQ (US Dollar)
$69.37
 Stock is Up 0.54 (0.78%)
Data as of 02/23/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote